These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 22714864)
1. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864 [TBL] [Abstract][Full Text] [Related]
2. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. Win AK; Lindor NM; Young JP; Macrae FA; Young GP; Williamson E; Parry S; Goldblatt J; Lipton L; Winship I; Leggett B; Tucker KM; Giles GG; Buchanan DD; Clendenning M; Rosty C; Arnold J; Levine AJ; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Hopper JL; Jenkins MA J Natl Cancer Inst; 2012 Sep; 104(18):1363-72. PubMed ID: 22933731 [TBL] [Abstract][Full Text] [Related]
3. Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28]. See WA Urol Oncol; 2013 Jul; 31(5):716. PubMed ID: 23796201 [TBL] [Abstract][Full Text] [Related]
4. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. Win AK; Lindor NM; Winship I; Tucker KM; Buchanan DD; Young JP; Rosty C; Leggett B; Giles GG; Goldblatt J; Macrae FA; Parry S; Kalady MF; Baron JA; Ahnen DJ; Marchand LL; Gallinger S; Haile RW; Newcomb PA; Hopper JL; Jenkins MA J Natl Cancer Inst; 2013 Feb; 105(4):274-9. PubMed ID: 23385444 [TBL] [Abstract][Full Text] [Related]
5. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome. Dominguez-Valentin M; Joost P; Therkildsen C; Jonsson M; Rambech E; Nilbert M BMC Urol; 2016 Mar; 16():15. PubMed ID: 27013479 [TBL] [Abstract][Full Text] [Related]
6. Prediction of Lynch syndrome in consecutive patients with colorectal cancer. Green RC; Parfrey PS; Woods MO; Younghusband HB J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167 [TBL] [Abstract][Full Text] [Related]
7. High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry. Rosty C; Walsh MD; Lindor NM; Thibodeau SN; Mundt E; Gallinger S; Aronson M; Pollett A; Baron JA; Pearson S; Clendenning M; Walters RJ; Nagler BN; Crawford WJ; Young JP; Winship I; Win AK; Hopper JL; Jenkins MA; Buchanan DD Fam Cancer; 2014 Dec; 13(4):573-82. PubMed ID: 25117503 [TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Walsh MD; Buchanan DD; Cummings MC; Pearson SA; Arnold ST; Clendenning M; Walters R; McKeone DM; Spurdle AB; Hopper JL; Jenkins MA; Phillips KD; Suthers GK; George J; Goldblatt J; Muir A; Tucker K; Pelzer E; Gattas MR; Woodall S; Parry S; Macrae FA; Haile RW; Baron JA; Potter JD; Le Marchand L; Bapat B; Thibodeau SN; Lindor NM; McGuckin MA; Young JP Clin Cancer Res; 2010 Apr; 16(7):2214-24. PubMed ID: 20215533 [TBL] [Abstract][Full Text] [Related]
9. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217 [TBL] [Abstract][Full Text] [Related]
10. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186 [TBL] [Abstract][Full Text] [Related]
11. Cancer Risks for PMS2-Associated Lynch Syndrome. Ten Broeke SW; van der Klift HM; Tops CMJ; Aretz S; Bernstein I; Buchanan DD; de la Chapelle A; Capella G; Clendenning M; Engel C; Gallinger S; Gomez Garcia E; Figueiredo JC; Haile R; Hampel HL; Hopper JL; Hoogerbrugge N; von Knebel Doeberitz M; Le Marchand L; Letteboer TGW; Jenkins MA; Lindblom A; Lindor NM; Mensenkamp AR; Møller P; Newcomb PA; van Os TAM; Pearlman R; Pineda M; Rahner N; Redeker EJW; Olderode-Berends MJW; Rosty C; Schackert HK; Scott R; Senter L; Spruijt L; Steinke-Lange V; Suerink M; Thibodeau S; Vos YJ; Wagner A; Winship I; Hes FJ; Vasen HFA; Wijnen JT; Nielsen M; Win AK J Clin Oncol; 2018 Oct; 36(29):2961-2968. PubMed ID: 30161022 [TBL] [Abstract][Full Text] [Related]
12. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922 [TBL] [Abstract][Full Text] [Related]
13. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening. Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703 [TBL] [Abstract][Full Text] [Related]
15. Hereditary prostate cancer as a feature of Lynch syndrome. Bauer CM; Ray AM; Halstead-Nussloch BA; Dekker RG; Raymond VM; Gruber SB; Cooney KA Fam Cancer; 2011 Mar; 10(1):37-42. PubMed ID: 20872076 [TBL] [Abstract][Full Text] [Related]
16. Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes. Ponz de Leon M; Pedroni M; Pezzi A; Sulce B; Roncucci L; Domati F; Rossi G; Reggiani Bonetti L Scand J Gastroenterol; 2018 Jan; 53(1):31-37. PubMed ID: 29025352 [TBL] [Abstract][Full Text] [Related]
17. Evidence for breast cancer as an integral part of Lynch syndrome. Buerki N; Gautier L; Kovac M; Marra G; Buser M; Mueller H; Heinimann K Genes Chromosomes Cancer; 2012 Jan; 51(1):83-91. PubMed ID: 22034109 [TBL] [Abstract][Full Text] [Related]
18. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States. Kastrinos F; Stoffel EM; Balmaña J; Steyerberg EW; Mercado R; Syngal S Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2044-51. PubMed ID: 18708397 [TBL] [Abstract][Full Text] [Related]
19. Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation. Stupart DA; Goldberg PA; Algar U; Ramesar R Fam Cancer; 2009; 8(4):519-23. PubMed ID: 19688281 [TBL] [Abstract][Full Text] [Related]